Join
Live feed
·
INSIDERFilingvia Quantisnow
NewAmsterdam Pharma Company N.V. logo

Chief Scientific Officer Kastelein Johannes Jacob Pieter converted options into 125,000 units of Ordinary Shares and sold $3,363,750 worth of Ordinary Shares (125,000 units at $26.91) as part of a pre-agreed trading plan (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NAMS· NewAmsterdam Pharma Company N.V.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAMS (NewAmsterdam Pharma Company N.V.) and more on Quantisnow.